메뉴 건너뛰기




Volumn 7, Issue 4, 2011, Pages 253-259

CD133, stem cells, and cancer stem cells: Myth or reality?

Author keywords

Cancer stem cells; CD133; Colorectal cancer; Endothelial progenitors

Indexed keywords

ANTINEOPLASTIC AGENT; AZD 7762; BEVACIZUMAB; CD133 ANTIGEN; ERLOTINIB; MESSENGER RNA; SALINOMYCIN; SORAFENIB; TUMOR MARKER; UNCLASSIFIED DRUG;

EID: 84856216836     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-011-0106-1     Document Type: Article
Times cited : (36)

References (83)
  • 2
    • 0031468289 scopus 로고    scopus 로고
    • A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning
    • Miraglia S, GodfreyW, YinAH, et al.: A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997;90:5013-21. This is the first paper to clone the CD133. (Pubitemid 28007218)
    • (1997) Blood , vol.90 , Issue.12 , pp. 5013-5021
    • Miraglia, S.1    Godfrey, W.2    Yin, A.H.3    Atkins, K.4    Warnke, R.5    Holden, J.T.6    Bray, R.A.7    Waller, E.K.8    Buck, D.W.9
  • 5
    • 33846095137 scopus 로고    scopus 로고
    • Identification and expansion of human colon-cancer-initiating cells
    • DOI 10.1038/nature05384, PII NATURE05384
    • Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al.: Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111-5. This is the first paper to isolate colon cancer stem cells. (Pubitemid 46067311)
    • (2007) Nature , vol.445 , Issue.7123 , pp. 111-115
    • Ricci-Vitiani, L.1    Lombardi, D.G.2    Pilozzi, E.3    Biffoni, M.4    Todaro, M.5    Peschle, C.6    De Maria, R.7
  • 7
    • 59049087696 scopus 로고    scopus 로고
    • Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation
    • Zhu L, Gibson P, Currle DS, et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature. 2009;457:603-7.
    • (2009) Nature , vol.457 , pp. 603-607
    • Zhu, L.1    Gibson, P.2    Currle, D.S.3
  • 8
    • 40749150740 scopus 로고    scopus 로고
    • + HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway
    • DOI 10.1038/sj.onc.1210811, PII 1210811
    • Ma S, Lee TK, Zheng BJ, et al. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene. 2008;27:1749-58. (Pubitemid 351380265)
    • (2008) Oncogene , vol.27 , Issue.12 , pp. 1749-1758
    • Ma, S.1    Lee, T.K.2    Zheng, B.-J.3    Chan, K.W.4    Guan, X.-Y.5
  • 9
    • 49949111381 scopus 로고    scopus 로고
    • Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells
    • Chen YC, Hsu HS, Chen YW, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One. 2008;3:e2637.
    • (2008) PLoS One , vol.3
    • Chen, Y.C.1    Hsu, H.S.2    Chen, Y.W.3
  • 10
    • 79955632648 scopus 로고    scopus 로고
    • Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells
    • Stewart JM, Shaw PA, Gedye C, et al. Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells. Proc Natl Acad Sci USA. 2011;108:6468-73.
    • (2011) Proc Natl Acad Sci USA , vol.108 , pp. 6468-6473
    • Stewart, J.M.1    Shaw, P.A.2    Gedye, C.3
  • 11
    • 70349479538 scopus 로고    scopus 로고
    • Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
    • Bertolini G, Roz L, Perego P, et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA. 2009;106:16281-6.
    • (2009) Proc Natl Acad Sci USA , vol.106 , pp. 16281-16286
    • Bertolini, G.1    Roz, L.2    Perego, P.3
  • 12
    • 57649140583 scopus 로고    scopus 로고
    • Generation of a prostate from a single adult stem cell
    • Leong KG, Wang BE, Johnson L, Gao WQ. Generation of a prostate from a single adult stem cell. Nature. 2008;456:804-8.
    • (2008) Nature , vol.456 , pp. 804-808
    • Leong, K.G.1    Wang, B.E.2    Johnson, L.3    Gao, W.Q.4
  • 13
    • 51649111430 scopus 로고    scopus 로고
    • Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity
    • Vermeulen L, Todaro M, de Sousa Mello F, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA. 2008;105:13427-32.
    • (2008) Proc Natl Acad Sci USA , vol.105 , pp. 13427-13432
    • Vermeulen, L.1    Todaro, M.2    De Sousa, M.F.3
  • 14
    • 78650098659 scopus 로고    scopus 로고
    • Glioblastoma stemlike cells give rise to tumour endothelium
    • This paper links the stem cells to tumor angiogenesis directly via CD133-expressing cells
    • Wang R, Chadalavada K, Wilshire J, et al.: Glioblastoma stemlike cells give rise to tumour endothelium. Nature 2010;468:829-33. This paper links the stem cells to tumor angiogenesis directly via CD133-expressing cells.
    • (2010) Nature , vol.468 , pp. 829-833
    • Wang, R.1    Chadalavada, K.2    Wilshire, J.3
  • 16
    • 28244472369 scopus 로고    scopus 로고
    • Prospective identification of tumorigenic prostate cancer stem cells
    • DOI 10.1158/0008-5472.CAN-05-2018
    • Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005;65:10946-51. (Pubitemid 41713363)
    • (2005) Cancer Research , vol.65 , Issue.23 , pp. 10946-10951
    • Collins, A.T.1    Berry, P.A.2    Hyde, C.3    Stower, M.J.4    Maitland, N.J.5
  • 17
    • 33847052127 scopus 로고    scopus 로고
    • Identification of pancreatic cancer stem cells
    • Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67:1030-7.
    • (2007) Cancer Res , vol.67 , pp. 1030-1037
    • Li, C.1    Heidt, D.G.2    Dalerba, P.3
  • 19
    • 65949112714 scopus 로고    scopus 로고
    • Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis
    • Huang EH, Hynes MJ, Zhang T, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 2009;69:3382-9.
    • (2009) Cancer Res , vol.69 , pp. 3382-3389
    • Huang, E.H.1    Hynes, M.J.2    Zhang, T.3
  • 20
    • 56149088742 scopus 로고    scopus 로고
    • Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene
    • Yin C, Lin Y, Zhang X, et al. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology. 2008;48:1528-39.
    • (2008) Hepatology. , vol.48 , pp. 1528-1539
    • Yin, C.1    Lin, Y.2    Zhang, X.3
  • 21
    • 0035499267 scopus 로고    scopus 로고
    • Stem cells, cancer, and cancer stem cells
    • DOI 10.1038/35102167
    • Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105-11. (Pubitemid 33041634)
    • (2001) Nature , vol.414 , Issue.6859 , pp. 105-111
    • Reya, T.1    Morrison, S.J.2    Clarke, M.F.3    Weissman, I.L.4
  • 22
    • 77952502408 scopus 로고    scopus 로고
    • A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth
    • Roesch A, Fukunaga-Kalabis M, Schmidt EC, et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell. 2010;141:583-94.
    • (2010) Cell , vol.141 , pp. 583-594
    • Roesch, A.1    Fukunaga-Kalabis, M.2    Schmidt, E.C.3
  • 23
    • 73149110562 scopus 로고    scopus 로고
    • Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content
    • Pece S, Tosoni D, Confalonieri S, et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell. 2010;140:62-73.
    • (2010) Cell , vol.140 , pp. 62-73
    • Pece, S.1    Tosoni, D.2    Confalonieri, S.3
  • 25
    • 79953042645 scopus 로고    scopus 로고
    • CD44: Can a cancer-initiating cell profit from an abundantly expressed molecule
    • Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer. 2011;11:254-67.
    • (2011) Nat Rev Cancer. , vol.11 , pp. 254-267
    • Zoller, M.1
  • 27
    • 59249094144 scopus 로고    scopus 로고
    • CD44 and EpCAM: Cancer-initiating cell markers
    • Marhaba R, Klingbeil P, Nuebel T, et al. CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med. 2008;8:784-804.
    • (2008) Curr Mol Med. , vol.8 , pp. 784-804
    • Marhaba, R.1    Klingbeil, P.2    Nuebel, T.3
  • 28
    • 0037424235 scopus 로고    scopus 로고
    • Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins
    • DOI 10.1074/jbc.M210640200
    • Fargeas CA, Florek M, Huttner WB, Corbeil D. Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins. J Biol Chem. 2003;278:8586-96. (Pubitemid 36800613)
    • (2003) Journal of Biological Chemistry , vol.278 , Issue.10 , pp. 8586-8596
    • Fargeas, C.A.1    Florek, M.2    Huttner, W.B.3    Corbeil, D.4
  • 29
    • 4944232476 scopus 로고    scopus 로고
    • Identification of novel prominin-1/CD133 splice variants with altrnative C-termini and their expression in epididymis and testis
    • DOI 10.1242/jcs.01315
    • Fargeas CA, Joester A,Missol-Kolka E, et al. Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J Cell Sci. 2004;117:4301-11. (Pubitemid 39328316)
    • (2004) Journal of Cell Science , vol.117 , Issue.18 , pp. 4301-4311
    • Fargeas, C.A.1    Joester, A.2    Missol-Kolka, E.3    Hellwig, A.4    Huttner, W.B.5    Corbeil, D.6
  • 30
    • 77951911233 scopus 로고    scopus 로고
    • The intriguing links between prominin-1 (CD133), cholesterolbased membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation
    • Corbeil D, Marzesco AM, Wilsch-Brauninger M, Huttner WB. The intriguing links between prominin-1 (CD133), cholesterolbased membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation. FEBS Lett. 2010;584:1659-64.
    • (2010) FEBS Lett. , vol.584 , pp. 1659-1664
    • Corbeil, D.1    Marzesco, A.M.2    Wilsch-Brauninger, M.3    Huttner, W.B.4
  • 31
    • 0032940090 scopus 로고    scopus 로고
    • Selective localization of the polytopic membrane protein prominin in microvilli of epithelial cells - A combination of apical sorting and retention in plasma membrane protrusions
    • Corbeil D, Roper K, Hannah MJ, et al. Selective localization of the polytopic membrane protein prominin in microvilli of epithelial cells - a combination of apical sorting and retention in plasma membrane protrusions. J Cell Sci. 1999;112(Pt 7):1023-33. (Pubitemid 29182172)
    • (1999) Journal of Cell Science , vol.112 , Issue.7 , pp. 1023-1033
    • Corbeil, D.1    Roper, K.2    Hannah, M.J.3    Hellwig, A.4    Huttner, W.B.5
  • 32
    • 76649089339 scopus 로고    scopus 로고
    • Microenvironmental modulation of asymmetric cell division in human lung cancer cells
    • This is the first paper to link CD133 to asymmetric division in lung cancer cells
    • Pine SR, Ryan BM, Varticovski L, et al.: Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proc Natl Acad Sci USA 2010;107:2195-200. This is the first paper to link CD133 to asymmetric division in lung cancer cells.
    • (2010) Proc Natl Acad Sci USA , vol.107 , pp. 2195-2200
    • Pine, S.R.1    Ryan, B.M.2    Varticovski, L.3
  • 33
    • 79951668217 scopus 로고    scopus 로고
    • Stem cell marker prominin-1 regulates branching morphogenesis, but not regenerative capacity
    • Dev Dyn 2011
    • Anderson LH, Boulanger CA, Smith GH, et al.: Stem cell marker prominin-1 regulates branching morphogenesis, but not regenerative capacity, in the mammary gland. Dev Dyn 2011.
    • The Mammary Gland
    • Anderson, L.H.1    Boulanger, C.A.2    Smith, G.H.3
  • 34
    • 45549091414 scopus 로고    scopus 로고
    • Prostate cancer stem cells: A new target for therapy
    • Maitland NJ, Collins AT. Prostate cancer stem cells: a new target for therapy. J Clin Oncol. 2008;26:2862-70.
    • (2008) J Clin Oncol. , vol.26 , pp. 2862-2870
    • Maitland, N.J.1    Collins, A.T.2
  • 35
    • 34548455927 scopus 로고    scopus 로고
    • Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
    • DOI 10.1016/j.stem.2007.06.002, PII S1934590907000665
    • Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1:313-23. (Pubitemid 47355323)
    • (2007) Cell Stem Cell , vol.1 , Issue.3 , pp. 313-323
    • Hermann, P.C.1    Huber, S.L.2    Herrler, T.3    Aicher, A.4    Ellwart, J.W.5    Guba, M.6    Bruns, C.J.7    Heeschen, C.8
  • 36
    • 54249143589 scopus 로고    scopus 로고
    • Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, andmelanoma cell lines
    • Jaksch M, Munera J, Bajpai R, et al. Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, andmelanoma cell lines. Cancer Res. 2008;68:7882-6.
    • (2008) Cancer Res. , vol.68 , pp. 7882-7886
    • Jaksch, M.1    Munera, J.2    Bajpai, R.3
  • 37
    • 78650315639 scopus 로고    scopus 로고
    • CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche
    • Kim M, Koh YJ, Kim KE, et al. CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res. 2010;70:10411-21.
    • (2010) Cancer Res. , vol.70 , pp. 10411-10421
    • Kim, M.1    Koh, Y.J.2    Kim, K.E.3
  • 38
    • 33846100356 scopus 로고    scopus 로고
    • A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
    • DOI 10.1038/nature05372, PII NATURE05372
    • O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445:106-10. (Pubitemid 46067310)
    • (2007) Nature , vol.445 , Issue.7123 , pp. 106-110
    • O'Brien, C.A.1    Pollett, A.2    Gallinger, S.3    Dick, J.E.4
  • 39
    • 79952011719 scopus 로고    scopus 로고
    • CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma
    • Shimada M, Sugimoto K, Iwahashi S, et al. CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma. J Gastroenterol. 2010;45:896-902.
    • (2010) J Gastroenterol. , vol.45 , pp. 896-902
    • Shimada, M.1    Sugimoto, K.2    Iwahashi, S.3
  • 40
    • 51649119918 scopus 로고    scopus 로고
    • Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations
    • Ma S, Chan KW, Lee TK, et al. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res. 2008;6:1146-53.
    • (2008) Mol Cancer Res. , vol.6 , pp. 1146-1153
    • Ma, S.1    Chan, K.W.2    Lee, T.K.3
  • 41
    • 79957917044 scopus 로고    scopus 로고
    • Aldehyde dehydrogenase and CD133 define angiogenic ovarian cancer stem cells that portend poor patient survival
    • Silva IA, Bai S, McLean K, et al.: Aldehyde dehydrogenase and CD133 define angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res 2011.
    • (2011) Cancer Res
    • Silva, I.A.1    Bai, S.2    McLean, K.3
  • 42
    • 67649359505 scopus 로고    scopus 로고
    • CD133 and nuclear beta-catenin: The marker combination to detect high risk cases of low stage colorectal cancer
    • Horst D, Kriegl L, Engel J, et al. CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer. Eur J Cancer. 2009;45:2034-40.
    • (2009) Eur J Cancer. , vol.45 , pp. 2034-2040
    • Horst, D.1    Kriegl, L.2    Engel, J.3
  • 43
    • 70349754442 scopus 로고    scopus 로고
    • MTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells
    • Matsumoto K, Arao T, Tanaka K, et al. mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells. Cancer Res. 2009;69:7160-4.
    • (2009) Cancer Res. , vol.69 , pp. 7160-7164
    • Matsumoto, K.1    Arao, T.2    Tanaka, K.3
  • 44
    • 54249127417 scopus 로고    scopus 로고
    • Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors
    • Yi JM, Tsai HC, Glockner SC, et al. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res. 2008;68:8094-103.
    • (2008) Cancer Res. , vol.68 , pp. 8094-8103
    • Yi, J.M.1    Tsai, H.C.2    Glockner, S.C.3
  • 45
    • 58249095085 scopus 로고    scopus 로고
    • Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
    • Baba T, Convery PA, Matsumura N, et al. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene. 2009;28:209-18.
    • (2009) Oncogene. , vol.28 , pp. 209-218
    • Baba, T.1    Convery, P.A.2    Matsumura, N.3
  • 46
    • 78449255989 scopus 로고    scopus 로고
    • MiR-200a regulates epithelialmesenchymal to stem-like transition via ZEB2 and beta-catenin signaling
    • Xia H, Cheung WK, Sze J, et al. miR-200a regulates epithelialmesenchymal to stem-like transition via ZEB2 and beta-catenin signaling. J Biol Chem. 2010;285:36995-7004.
    • (2010) J Biol Chem. , vol.285 , pp. 36995-37004
    • Xia, H.1    Cheung, W.K.2    Sze, J.3
  • 47
    • 78649681554 scopus 로고    scopus 로고
    • MiR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1
    • Ma S, Tang KH, Chan YP, et al. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell. 2010;7:694-707.
    • (2010) Cell Stem Cell. , vol.7 , pp. 694-707
    • Ma, S.1    Tang, K.H.2    Chan, Y.P.3
  • 48
    • 69949087531 scopus 로고    scopus 로고
    • MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells
    • Ji Q, Hao X, Zhang M, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One. 2009;4: e6816.
    • (2009) PLoS One. , vol.4
    • Ji, Q.1    Hao, X.2    Zhang, M.3
  • 49
    • 79952119592 scopus 로고    scopus 로고
    • A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations
    • This is the first paper to describe a CD133-related gene expression signature in GBM, and these signatures are shared among other tumor types
    • Yan X, Ma L, Yi D, et al.: A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations. Proc Natl Acad Sci USA 2011;108:1591-6. This is the first paper to describe a CD133-related gene expression signature in GBM, and these signatures are shared among other tumor types.
    • (2011) Proc Natl Acad Sci USA , vol.108 , pp. 1591-1596
    • Yan, X.1    Ma, L.2    Yi, D.3
  • 50
    • 77951192102 scopus 로고    scopus 로고
    • Stem-like cancer cells are inducible by increasing genomic instability in cancer cells
    • Liang Y, Zhong Z, Huang Y, et al. Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. J Biol Chem. 2010;285:4931-40.
    • (2010) J Biol Chem. , vol.285 , pp. 4931-4940
    • Liang, Y.1    Zhong, Z.2    Huang, Y.3
  • 51
    • 68349114796 scopus 로고    scopus 로고
    • Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
    • Li CY, Li BX, Liang Y, et al. Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB. J Transl Med. 2009;7:56.
    • (2009) J Transl Med. , vol.7 , pp. 56
    • Li, C.Y.1    Li, B.X.2    Liang, Y.3
  • 52
    • 79956309778 scopus 로고    scopus 로고
    • Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma
    • Xi HQ, Zhao P: Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma. J Clin Pathol 2011.
    • (2011) J Clin Pathol
    • Xi, H.Q.1    Zhao, P.2
  • 53
    • 75449109041 scopus 로고    scopus 로고
    • Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients
    • Prognostic value of CD133 mRNA in colorectal cancer is proposed
    • Artells R, Moreno I, Diaz T, et al.: Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Eur J Cancer 2010;46:642-9. Prognostic value of CD133 mRNA in colorectal cancer is proposed.
    • (2010) Eur J Cancer , vol.46 , pp. 642-649
    • Artells, R.1    Moreno, I.2    Diaz, T.3
  • 54
    • 53849134099 scopus 로고    scopus 로고
    • CD133 expression is an independent prognostic marker for low survival in colorectal cancer
    • Horst D, Kriegl L, Engel J, et al. CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer. 2008;99:1285-9.
    • (2008) Br J Cancer. , vol.99 , pp. 1285-1289
    • Horst, D.1    Kriegl, L.2    Engel, J.3
  • 55
    • 77955073877 scopus 로고    scopus 로고
    • Prognostic impact of CD133 expression in gastric carcinoma
    • Ishigami S, Ueno S, Arigami T, et al. Prognostic impact of CD133 expression in gastric carcinoma. Anticancer Res. 2010;30:2453-7.
    • (2010) Anticancer Res. , vol.30 , pp. 2453-2457
    • Ishigami, S.1    Ueno, S.2    Arigami, T.3
  • 56
    • 80052709582 scopus 로고    scopus 로고
    • Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: A prospective patient cohort at a single institution
    • Metellus P, Nanni-Metellus I, Delfino C, et al.: Prognostic Impact of CD133 mRNA Expression in 48 Glioblastoma Patients Treated with Concomitant Radiochemotherapy: A Prospective Patient Cohort at a Single Institution. Ann Surg Oncol 2011.
    • (2011) Ann Surg Oncol
    • Metellus, P.1    Nanni-Metellus, I.2    Delfino, C.3
  • 57
    • 77954361859 scopus 로고    scopus 로고
    • Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma
    • Sasaki A, Kamiyama T, Yokoo H, et al. Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma. Oncol Rep. 2010;24:537-46.
    • (2010) Oncol Rep. , vol.24 , pp. 537-546
    • Sasaki, A.1    Kamiyama, T.2    Yokoo, H.3
  • 58
    • 77957948577 scopus 로고    scopus 로고
    • Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer
    • Nakamura M, Kyo S, Zhang B, et al. Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer. Hum Pathol. 2010;41:1516-29.
    • (2010) Hum Pathol. , vol.41 , pp. 1516-1529
    • Nakamura, M.1    Kyo, S.2    Zhang, B.3
  • 59
    • 79955106228 scopus 로고    scopus 로고
    • Prognostic value of CD133 expression in stage I lung adenocarcinomas
    • Woo T, Okudela K, Mitsui H, et al. Prognostic value of CD133 expression in stage I lung adenocarcinomas. Int J Clin Exp Pathol. 2010;4:32-42.
    • (2010) Int J Clin Exp Pathol. , vol.4 , pp. 32-42
    • Woo, T.1    Okudela, K.2    Mitsui, H.3
  • 60
    • 52449091004 scopus 로고    scopus 로고
    • Drug-selected human lung cancer stem cells: Cytokine network, tumorigenic and metastatic properties
    • Levina V, Marrangoni AM, DeMarco R, et al. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One. 2008;3:e3077.
    • (2008) PLoS One. , vol.3
    • Levina, V.1    Marrangoni, A.M.2    DeMarco, R.3
  • 63
    • 46449115281 scopus 로고    scopus 로고
    • Stem cell-related "selfrenewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
    • Murat A, Migliavacca E, Gorlia T, et al. Stem cell-related "selfrenewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol. 2008;26:3015-24.
    • (2008) J Clin Oncol. , vol.26 , pp. 3015-3024
    • Murat, A.1    Migliavacca, E.2    Gorlia, T.3
  • 64
    • 71549155909 scopus 로고    scopus 로고
    • Correlation of CD133 OCT4 and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy
    • Saigusa S, Tanaka K, Toiyama Y, et al. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol. 2009;16:3488-98.
    • (2009) Ann Surg Oncol. , vol.16 , pp. 3488-3498
    • Saigusa, S.1    Tanaka, K.2    Toiyama, Y.3
  • 65
    • 79953234572 scopus 로고    scopus 로고
    • Expression of cancer stem cell markers CD133 and CD44 in locoregional recurrence of rectal cancer
    • Nagata T, Sakakura C, Komiyama S, et al. Expression of cancer stem cell markers CD133 and CD44 in locoregional recurrence of rectal cancer. Anticancer Res. 2011;31:495-500.
    • (2011) Anticancer Res. , vol.31 , pp. 495-500
    • Nagata, T.1    Sakakura, C.2    Komiyama, S.3
  • 68
    • 34547106802 scopus 로고    scopus 로고
    • Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence
    • DOI 10.1002/cncr.22774
    • Lin EH, Hassan M, Li Y, et al.: Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer 2007;110:534-42. This is the first paper to describe the prognostic value of CD133 mRNA in colorectal cancer. (Pubitemid 47106141)
    • (2007) Cancer , vol.110 , Issue.3 , pp. 534-542
    • Lin, E.H.1    Hassan, M.2    Li, Y.3    Zhao, H.4    Nooka, A.5    Sorenson, E.6    Xie, K.7    Champlin, R.8    Wu, X.9    Li, D.10
  • 71
    • 79955030814 scopus 로고    scopus 로고
    • Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' Stage B and C colorectal cancer
    • This is the first paper to describe the role of CD133 mRNA in stage B and C colorectal cancer
    • Iinuma H, Watanabe T, Mimori K, et al.: Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' Stage B and C Colorectal Cancer. J Clin Oncol 2011. This is the first paper to describe the role of CD133 mRNA in stage B and C colorectal cancer.
    • (2011) J Clin Oncol
    • Iinuma, H.1    Watanabe, T.2    Mimori, K.3
  • 72
    • 33947505827 scopus 로고    scopus 로고
    • Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer
    • Iinuma H, Okinaga K, Egami H, et al. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int J Oncol. 2006;28:297-306.
    • (2006) Int J Oncol. , vol.28 , pp. 297-306
    • Iinuma, H.1    Okinaga, K.2    Egami, H.3
  • 73
    • 77954269426 scopus 로고    scopus 로고
    • Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery
    • Nakamura K, Iinuma H, Aoyagi Y, et al. Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery. Oncology. 2010;78:309-15.
    • (2010) Oncology. , vol.78 , pp. 309-315
    • Nakamura, K.1    Iinuma, H.2    Aoyagi, Y.3
  • 74
    • 74149087446 scopus 로고    scopus 로고
    • Perioperative tumor cell dissemination in patients with primary or metastatic colorectal cancer
    • Tralhao JG, Hoti E, Serodio M, et al. Perioperative tumor cell dissemination in patients with primary or metastatic colorectal cancer. Eur J Surg Oncol. 2010;36:125-9.
    • (2010) Eur J Surg Oncol. , vol.36 , pp. 125-129
    • Tralhao, J.G.1    Hoti, E.2    Serodio, M.3
  • 75
    • 75549091170 scopus 로고    scopus 로고
    • CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients
    • Vroling L, Lind JS, de Haas RR, et al. CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients. Br J Cancer. 2010;102:268-75.
    • (2010) Br J Cancer. , vol.102 , pp. 268-275
    • Vroling, L.1    Lind, J.S.2    De Haas, R.R.3
  • 77
    • 73349127099 scopus 로고    scopus 로고
    • Predictive potential of angiogenic growth factors and circulating endothelial cells in breast cancer patients receiving metronomic chemotherapy plus bevacizumab
    • Calleri A, Bono A, Bagnardi V, et al. Predictive potential of angiogenic growth factors and circulating endothelial cells in breast cancer patients receiving metronomic chemotherapy plus bevacizumab. Clin Cancer Res. 2009;15:7652-7.
    • (2009) Clin Cancer Res. , vol.15 , pp. 7652-7657
    • Calleri, A.1    Bono, A.2    Bagnardi, V.3
  • 79
    • 68549107867 scopus 로고    scopus 로고
    • Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells
    • Gedye C, Quirk J, Browning J, et al. Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells. Cancer Immunol Immunother. 2009;58:1635-46.
    • (2009) Cancer Immunol Immunother. , vol.58 , pp. 1635-1646
    • Gedye, C.1    Quirk, J.2    Browning, J.3
  • 80
    • 58049201990 scopus 로고    scopus 로고
    • The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma
    • Rappa G, Fodstad O, Lorico A. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells. 2008;26:3008-17.
    • (2008) Stem Cells. , vol.26 , pp. 3008-3017
    • Rappa, G.1    Fodstad, O.2    Lorico, A.3
  • 81
    • 68749099671 scopus 로고    scopus 로고
    • Identification of selective inhibitors of cancer stem cells by high-throughput screening
    • Gupta PB, Onder TT, Jiang G, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009;138:645-59.
    • (2009) Cell. , vol.138 , pp. 645-659
    • Gupta, P.B.1    Onder, T.T.2    Jiang, G.3
  • 82
    • 70349638289 scopus 로고    scopus 로고
    • Tumour-initiating cells: Challenges and opportunities for anticancer drug discovery
    • Zhou BB, Zhang H, Damelin M, et al. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov. 2009;8:806-23.
    • (2009) Nat Rev Drug Discov. , vol.8 , pp. 806-823
    • Zhou, B.B.1    Zhang, H.2    Damelin, M.3
  • 83
    • 84856228013 scopus 로고    scopus 로고
    • Efficiently targeting cancer stem cells requires tactical activation from their dormant state and subsequent exhaustion
    • Lin E, He X, Yan XW, et al.: Efficiently targeting cancer stem cells requires tactical activation from their dormant state and subsequent exhaustion. Proceedings of American Association of Cancer Research 2010;LB254.
    • (2010) Proceedings of American Association of Cancer Research
    • Lin, E.1    He, X.2    Yan, X.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.